• nor-NOHA Acetate in Cancer Immunometabolism: Beyond Arginase

  2026-08-04

  Explore how nor-NOHA acetate modulates arginine metabolism and immune escape in cancer models. This article uniquely bridges arginase inhibition with recent advances in lipid-driven immunosuppression, offering deeper application insight for researchers.

• Gepotidacin’s Novel Mechanism and Clinical Promise in AMR UT

  2026-08-04

  This review highlights Gepotidacin’s unique dual-topoisomerase inhibition, offering a new oral therapeutic option for uncomplicated UTIs and urogenital gonorrhea amid rising antimicrobial resistance. The reference study details its distinct mechanism, promising clinical performance, and the need for innovative agents in the face of multidrug-resistant pathogens.

• Neuronal lncRNA EDAL Drives EZH2 Degradation for Antiviral D

  2026-08-03

  Sui et al. (2020) identified a novel neuronal lncRNA, EDAL, which inhibits replication of multiple neurotropic viruses by targeting EZH2 for lysosomal degradation via shielding its T309 O-GlcNAcylation site. This mechanism reveals a non-canonical antiviral pathway in neurons, expanding our understanding of epigenetic regulation in CNS viral infections.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Innovations

  2026-08-03

  This review highlights recent advances in CXCR4-targeted molecular imaging and theranostics for lymphoma. Integrating peptide-based radiotracers and CXCR4 antagonists, the study illuminates how precision targeting of CXCR4 enhances diagnosis, prognostication, and therapeutic response in aggressive lymphomas.

• Torin2 in mTOR Pathway Research: Advanced Mechanisms and Ass

  2026-08-02

  Explore how Torin2, a potent mTOR inhibitor, enables deeper dissection of cancer cell responses and assay design. This article reveals advanced mechanisms of action and practical assay implications not covered elsewhere.

• Anlotinib Hydrochloride: Precision Angiogenesis Inhibition D

  2026-08-01

  Explore the scientific foundation of Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor, emphasizing its unprecedented selectivity, mechanistic depth, and translational impact on angiogenesis and cancer research. Gain unique insights into assay design and evidence-driven application strategies.

• G-15: Applied Workflows for G Protein-Coupled Estrogen Recep

  2026-07-31

  G-15 enables precise modulation of GPR30-driven estrogen signaling, empowering advanced mechanistic studies and translational models. This guide synthesizes protocol parameters, workflow innovations, and troubleshooting for researchers targeting non-classical estrogen pathways.

• A-1210477: Selective MCL-1 Inhibitor for Apoptosis Induction

  2026-07-31

  A-1210477 is a potent, selective MCL-1 inhibitor that disrupts cancer cell survival by targeting the canonical anti-apoptotic function of MCL-1. This compound offers high affinity, specificity, and synergy with established BCL-2 inhibitors, making it a valuable research tool for mitochondrial apoptosis studies in cancer. Its properties and limitations are critical for designing robust in vitro assays.

• Asiaticoside Modulates TGF-β1-Driven Fibrosis via Nrf2/HO-1

  2026-07-30

  Zhao et al. reveal that asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition (MMT) and oxidative stress in human peritoneal mesothelial cells by activating Nrf2/HO-1 signaling and suppressing Smad2/3 phosphorylation. Their mechanistic work advances understanding of peritoneal fibrosis and identifies intersecting anti-fibrotic and antioxidant pathways relevant for translational research.

• pH-Responsive Hairpin ASO Prodrugs: Structure-Guided Tumor T

  2026-07-30

  This study introduces a novel class of pH-responsive hairpin antisense oligonucleotide (ASO) prodrugs leveraging the i-motif for controlled release and enhanced gene silencing in MYCN-amplified tumor cells. Structure–activity optimization enabled acid-triggered, stable delivery, offering a blueprint for rational design of stimuli-responsive nucleic acid therapeutics.

• One-step TUNEL FITC Apoptosis Detection Kit: Applied Workflo

  2026-07-29

  The One-step TUNEL FITC Apoptosis Detection Kit streamlines apoptosis detection with direct FITC-labeled dUTP incorporation, enabling sensitive and reproducible DNA fragmentation assays in both tissue sections and cultured cells. This article explores experimental workflows, advanced troubleshooting, and insights from recent ovarian research to optimize your apoptosis studies.

• VX-745: Precision p38α MAPK Inhibition and Dephosphorylation

  2026-07-29

  Explore the distinct mechanistic and assay implications of VX-745, a potent p38α MAPK inhibitor, with a focus on dephosphorylation dynamics. This article offers a unique perspective for researchers seeking to optimize inflammation and cancer models.

• CCK-8 Ammonium Suppresses IgG1 Production in Activated B Cel

  2026-07-28

  This study demonstrates that cholecystokinin octapeptide ammonium (CCK-8 ammonium) inhibits immunoglobulin G1 (IgG1) production in lipopolysaccharide-activated murine B cells, primarily through CCK2R-mediated modulation of key transcription factors. These findings advance our understanding of CCK-8 ammonium as a context-dependent immune modulator, with implications for autoimmune and inflammatory disease research.

• Taxus chinensis Fruit Attenuates Neuroinflammation via TLR4

  2026-07-28

  This study demonstrates that Taxus chinensis fruit extract (TCFE) reduces neuroinflammation and aging behaviors in a mouse model by suppressing microglial activation through the TLR4/NF-κB/NLRP3 pathway. The findings clarify molecular mechanisms underlying TCFE's anti-aging effects and establish a preclinical foundation for translational research targeting neuroinflammation.

• γH2AX DNA Damage Detection Kit: Applied Workflows & Innovati

  2026-07-27

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) empowers researchers to visualize and quantify DNA double-strand breaks with precision, enabling breakthroughs in cancer therapy and genotoxicity assessment. This article delivers protocol upgrades, troubleshooting solutions, and actionable insights inspired by recent radioimmunotherapy advances.

16759 records 1/1118 page Next 12345 下5页 Last page